Annals of Epidemiology
Volume 17, Issue 8 , Pages 615-621 , August 2007

Modeling Smoking History: A Comparison of Different Approaches in the MARS Study on Age-Related Maculopathy

Received 1 August 2006 ,Accepted 28 March 2007.

References 

  1. Chopdar A, Chakravarthy U, Verma D. Age related macular degeneration. BMJ. 2003;326:485–488
  2. Gottlieb JL. Age-related macular degeneration. JAMA. 2002;288:2233–2236
  3. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933–943
  4. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14:3227–3236
  5. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. Epidemiology of age-related maculopathy: a review. Eur J Epidemiol. 2003;18:845–854
  6. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227–7232
  7. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7–21
  8. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye. 2005;19:935–944
  9. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1518–1523
  10. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol. 2006;124:995–1001
  11. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol. 2002;120:1357–1363
  12. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137:190–200
  13. Smith BT, Belani S, Ho AC. Light energy, cataract surgery, and progression of age-related macular degeneration. Curr Opin Ophthalmol. 2005;16:166–169
  14. Guymer RH, Chong EW. Modifiable risk factors for age-related macular degeneration. Med J Aust. 2006;184:455–458
  15. Xu L, Li Y, Zheng Y, Jonas JB. Associated factors for age-related maculopathy in the adult population in China. The Beijing Eye Study. Br J Ophthalmol. 2006;90:1087–1090
  16. Dasch B, Fuhs A, Meister A, Behrens A, Krause K, Pauleikoff D, et al. [Association between classic cardiovascular risk factors and age-related maculopathy (ARM) Results of the baseline examination of the Munster Aging and Retina Study (MARS).]. Ophthalmologe. 2005;102:1057–1063
  17. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001;20:227–253
  18. Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A, Gallins P, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet. 2006;78:852–864
  19. Leffondré K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling smoking history: a comparison of different approaches. Am J Epidemiol. 2002;156:813–823
  20. Dasch B, Fuhs A, Schmidt J, Behrens T, Meister A, Wellmann J, et al. Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS). Graefes Arch Clin Exp Ophthalmol. 2005;243:1028–1035
  21. Dasch B, Fuhs A, Behrens T, Meister A, Wellmann J, Fobker M, et al. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol. 2005;123:1501–1506
  22. The international Age-Related Maculopathy Study Group . An international classification system for age-related maculopathy. Surv Ophthalomol. 1995;39:367–374
  23. Klaver CC, Assink J, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalomol Vis Sci. 2001;42:2237–2241
  24. Allison P. Multinomial Logit Analysis. Logistic regression using the SAS system: theory and application. New York: Wiley; 2002;
  25. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716–723
  26. SAS Institute Inc. SAS. [9.1.3]. Cary NC: SAS Institute; 2000;
  27. Lau JT, Lee V, Fan D, Lau M, Michon J. Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population. Br J Ophthalmol. 2002;86:1080–1084
  28. Livingston PM, McCarty CA, Taylor HR. Knowledge, attitudes, and self care practices associated with age related eye disease in Australia. Br J Ophthalmol. 1998;82:780–785
  29. Konstas AG, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye. 2000;14:752–756
  30. Junge B, Nagel M. [Smoking behavior in Germany]. Gesundheitswesen. 1999;61;Spec No: S121–S125

 This study was sponsored by Deutsche Forschungsgemeinschaft (Grants HE 2293/5-1 and 2293/5-2), by the ProRetina Foundation, and IMF Fund of the University of Muenster.

PII: S1047-2797(07)00139-1

doi: 10.1016/j.annepidem.2007.03.005

Annals of Epidemiology
Volume 17, Issue 8 , Pages 615-621 , August 2007

Article Tools

* Image Usage & Resolution